Brind.
  1. The United States Patent and Trademark Office granted a new composition of matter patent to a company.

USPTO granted Afecta Pharmaceuticals a new patent on August 25, 2026.

1 report, 1 independent Updated Aug 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

USPTO granted Afecta Pharmaceuticals a new patent on August 25, 2026.

Keep exploring

Part of

The United States Patent and Trademark Office granted a new composition of matter patent to a company. All 1 developments

Coverage

Newest first; wire copies grouped